 |
Rajvir Dahiya, PhD
Recent Publications |
Publications – 2008 |
 |
Hirata, H., Y. Hinoda, N. Okayama,
Y. Suehiro, K. Kawamoto, N. Kikuno, J.T. Rabban, L.M.
Chen, and R. Dahiya, COMT polymorphisms affecting protein
expression are risk factors for endometrial cancer.
Mol Carcinog, 2008. |
|
Hirata, H., Y. Hinoda, N. Okayama, Y. Suehiro, K.
Kawamoto, N. Kikuno, J.T. Rabban, L.M. Chen, and R.
Dahiya, CYP1A1, SULT1A1, and SULT1E1 polymorphisms are
risk factors for endometrial cancer susceptibility.
Cancer, 2008. |
|
Place, R.F., L.C. Li, D. Pookot, E.J.
Noonan, and R. Dahiya, MicroRNA-373 induces expression of
genes with complementary promoter sequences. Proc Natl Acad
Sci U S A, 2008. 105(5): p. 1608-13. |
| |
Publications – 2007 |
|
Hirata, H., Y. Hinoda, N. Kikuno, K.
Kawamoto, A.V. Dahiya, Y. Suehiro, Y. Tanaka, and R.
Dahiya,
CXCL12 G801A polymorphism is a risk factor for sporadic prostate
cancer susceptibility. Clin Cancer Res, 2007. 13(17): p.
5056-62. |
|
Hirata, H., Y. Hinoda, N. Kikuno, K.
Kawamoto, Y. Suehiro, Y. Tanaka, and R. Dahiya, MDM2 SNP309
polymorphism as risk factor for susceptibility and poor prognosis
in renal cell carcinoma. Clin Cancer Res, 2007. 13(14): p.
4123-9. |
|
Hirata, H., Y. Hinoda, Y. Tanaka, N. Okayama,
Y. Suehiro, K. Kawamoto, N. Kikuno, S. Majid, K. Vejdani,
and R. Dahiya, Polymorphisms of DNA repair genes are risk
factors for prostate cancer. Eur J Cancer, 2007. 43(2): p.
231-7. |
|
Kawamoto, K., S.T. Okino, R.F. Place, S.
Urakami, H. Hirata, N. Kikuno, T. Kawakami, Y. Tanaka, D.
Pookot, Z. Chen, S. Majid, H. Enokida, M. Nakagawa, and
R. Dahiya, Epigenetic modifications of RASSF1A gene through chromatin remodeling
in prostate cancer. Clin Cancer Res, 2007. 13(9): p. 2541-8. |
|
Kikuno, N., H. Shiina, S. Urakami, K. Kawamoto,
H. Hirata, Y. Tanaka, R.F. Place, D. Pookot, S. Majid, M.
Igawa, and R. Dahiya, Knockdown of astrocyte-elevated gene-1
inhibits prostate cancer progression through upregulation
of FOXO3a activity. Oncogene, 2007. 26(55): p. 7647-55. |
|
Li, L.C. and R. Dahiya, Epigenetics of prostate
cancer. Front Biosci., 2007. May 1(12): p. 3377-97. |
|
Okino, S.T., D. Pookot, S. Majid, H.
Zhao, L.C. Li, R.F. Place, and R. Dahiya, Chromatin changes
on the GSTP1 promoter associated with its inactivation in
prostate cancer. Mol Carcinog, 2007. 46(10): p. 839-46. |
|
Okino, S.T., L.C. Quattrochi, D. Pookot,
M. Iwahashi, and R. Dahiya, A dioxin-responsive enhancer
3' of the human CYP1A2 gene. Mol Pharmacol, 2007. 72(6):
p. 1457-65. |
|
Qin, J., L.P. Xie, X.Y. Zheng, Y.B. Wang,
Y. Bai, H.F. Shen, L.C. Li, and R. Dahiya, A component of
green tea, (-)-epigallocatechin-3-gallate, promotes apoptosis
in T24 human bladder cancer cells via modulation of the PI3K/Akt
pathway and Bcl-2 family proteins. Biochem Biophys Res Commun,
2007. 354(4): p. 852-7. |
|
Tanaka, Y., H. Hirata, Z. Chen, N. Kikuno,
K. Kawamoto, S. Majid, T. Tokizane, S. Urakami, H. Shiina,
K. Nakajima, R. Dhir, and R. Dahiya, Polymorphisms of catechol-O-methyltransferase
in men with renal cell cancer. Cancer Epidemiol Biomarkers
Prev, 2007. 16(1): p. 92-7. |
|
Urakami, S., H. Shiina, H. Enokida,
K. Kawamoto, N. Kikuno, T. Fandel, K. Vejdani, L. Nunes,
M. Igawa, E.A. Tanagho, and R. Dahiya, Functional improvement
in spinal cord injury-induced neurogenic bladder by bladder
augmentation using bladder acellular matrix graft in the
rat. World J Urol, 2007. 25(2): p. 207-13. |
| |
Publications – 2006 |
|
Enokida, H., H. Shiina, S. Urakami, M.
Terashima, T. Ogishima, L.C. Li, M. Kawahara, M. Nakagawa,
C.J. Kane, P.R. Carroll, M. Igawa, and R.
Dahiya, Smoking
influences aberrant CpG hypermethylation of multiple genes
in human prostate carcinoma. Cancer, 2006. 106(1): p. 79-86. |
|
Hirata, H., Y. Hinoda, H. Matsuyama, Y.
Tanaka, N. Okayama, Y. Suehiro, H. Zhao, S. Urakami, K. Kawamoto,
T. Kawakami, M. Igawa, K. Naito, and R.
Dahiya, Polymorphisms
of DNA repair genes are associated with renal cell carcinoma.
Biochem Biophys Res Commun, 2006. 342(4): p. 1058-62. |
|
Li, L.C., S.T. Okino, H. Zhao, D. Pookot,
R.F. Place, S. Urakami, H. Enokida, and R.
Dahiya, Small
dsRNAs induce transcriptional activation in human cells.
Proc Natl Acad Sci U S A, 2006. 103(46): p. 17337-42. |
|
Okino, S.T., D. Pookot, L.C. Li, H. Zhao,
S. Urakami, H. Shiina, M. Igawa, and R.
Dahiya, Epigenetic
inactivation of the dioxin-responsive cytochrome P4501A1
gene in human prostate cancer. Cancer Res, 2006. 66(15):
p. 7420-8. |
|
Pookot, D., L.C. Li, Z.L. Tabatabai, Y.
Tanaka, K.L. Greene, and R. Dahiya, The E-cadherin -160 C/A
polymorphism and prostate cancer risk in white and black
American men. J Urol, 2006. 176(2): p. 793-6. |
|
Shirai, M., M. Yamanaka, H. Shiina, M.
Igawa, T. Kawakami, N. Ishii, T.F. Lue, M. Fujime, and R.
Dahiya, Vascular endothelial growth factor restores erectile
function through modulation of the insulin-like growth factor
system and sex hormone receptors in diabetic rat. Biochem
Biophys Res Commun, 2006. 341(3): p. 755-62. |
|
Sievert, K.D., T. Fandel, J. Wefer, C.A.
Gleason, L. Nunes, R. Dahiya, and E.A. Tanagho, Collagen
I:III ratio in canine heterologous bladder acellular matrix
grafts. World J Urol, 2006. 24(1): p. 101-9. |
|
Tanaka, Y., M. Sasaki, H. Shiina, T. Tokizane,
M. Deguchi, H. Hirata, Y. Hinoda, N. Okayama, Y. Suehiro,
S. Urakami, T. Kawakami, M. Kaneuchi, D. Pookot, M. Igawa,
A. Okuyama, N. Ishii, and R. Dahiya, Catechol-O-methyltransferase
gene polymorphisms in benign prostatic hyperplasia and sporadic
prostate cancer. Cancer Epidemiol Biomarkers Prev, 2006.
15(2): p. 238-44. |
|
Urakami, S., H. Shiina, H. Enokida, H.
Hirata, K. Kawamoto, T. Kawakami, N. Kikuno, Y. Tanaka, S.
Majid, M. Nakagawa, M. Igawa, and R.
Dahiya, Wnt antagonist
family genes as biomarkers for diagnosis, staging, and prognosis
of renal cell carcinoma using tumor and serum DNA. Clin Cancer
Res, 2006. 12(23): p. 6989-97. |
|
Urakami, S., H. Shiina, H. Enokida, T.
Kawakami, K. Kawamoto, H. Hirata, Y. Tanaka, N. Kikuno, M.
Nakagawa, M. Igawa, and R. Dahiya, Combination analysis of
hypermethylated Wnt-antagonist family genes as a novel epigenetic
biomarker panel for bladder cancer detection. Clin Cancer
Res, 2006. 12(7 Pt 1): p. 2109-16. |
|
Urakami, S., H. Shiina, H. Enokida, T.
Kawakami, T. Tokizane, T. Ogishima, Y. Tanaka, L.C. Li, L.A.
Ribeiro-Filho, M. Terashima, N. Kikuno, H. Adachi, T. Yoneda,
H. Kishi, K. Shigeno, B.R. Konety, M. Igawa, and R.
Dahiya,
Epigenetic inactivation of Wnt inhibitory factor-1 plays
an important role in bladder cancer through aberrant canonical
Wnt/beta-catenin signaling pathway. Clin Cancer Res, 2006.
12(2): p. 383-91. |
| |
return
to top
|
|
|
|
|
|
